Persistent Truncus Arteriosus
(See also Overview of Congenital Cardiovascular Anomalies.)
Persistent truncus arteriosus (see figure Truncus arteriosus) accounts for about 1% of congenital heart anomalies and 4% of critical congenital heart defects. About 35% of patients have 22q11 deletion syndrome, which includes DiGeorge syndrome and velocardiofacial syndromes.
There are several classification systems in use.
The first classification, by Collett and Edwards, is
Type I: The main pulmonary artery arises from the truncus and then divides into the right and left pulmonary arteries.
Type II: The right and left pulmonary arteries arise separately (but adjacent to each other) from the posterior aspect of the truncus.
Type III: The right and left pulmonary arteries arise from the lateral aspects of the truncal root reasonably distant from each other.
Type IV: Both pulmonary arteries are supplied by collateral vessels from the descending aorta. (Type IV is now reclassified as tetralogy of Fallot with pulmonary atresia.)
An updated classification by Van Praagh consists of type A (truncus arteriosus withventricular septal defect [VSD]) and the very rare type B (truncus arteriosus without VSD). Type A is subdivided into 4 types:
Type A1: The main pulmonary artery arises from the truncus and then divides into right and left pulmonary arteries.
Type A2: The right and left pulmonary arteries arise separately from the posterior aspect of the truncus.
Type A3: One lung is supplied by a pulmonary artery branch that arises from the truncus and the other lung (usually the left) is supplied by a ductus-like collateral artery
Type A4: The truncus is a large pulmonary artery and the aortic arch is interrupted or coarctation is present.
The truncal valve may be quite abnormal and manifest with stenosis, regurgitation, or both. The valve is tricuspid in 69%, quadricuspid in 22%, and bicuspid in 9%. Other anomalies (eg, right aortic arch, interrupted aortic arch, coronary artery anomalies) may be present and may contribute to the high surgical mortality rate. A patent ductus arteriosus is present in about half of patients with truncus arteriosus, most notably those with types A3 and A4 defects.
Physiologic consequences of truncus arteriosus include mild cyanosis, significant pulmonary overcirculation, and heart failure.
Infants usually present with mild cyanosis and symptoms and signs of heart failure (eg, tachypnea, poor feeding, diaphoresis) in the first few weeks of life. Physical examination may detect a hyperdynamic precordium, increased pulse pressure with bounding pulses, a loud and single 2nd heart sound (S2), and an ejection click. A grade 2 to 4/6 systolic murmur is audible along the left sternal border (see table Heart Murmur Intensity). A mid-diastolic mitral flow murmur may be audible at the apex when pulmonary blood flow is increased. With truncal valve insufficiency, a high-pitched diastolic decrescendo murmur is audible over the mid left sternal border.
Diagnosis is suspected clinically, supported by chest x-ray and ECG, and established by 2-dimensional echocardiography with color flow and Doppler studies. Cardiac catheterization is occasionally necessary to delineate associated anomalies before surgery, but cardiac MRI or CT angiography may supplant the need for catheterization.
Chest x-ray shows varying degrees of cardiomegaly with increased pulmonary vascular markings, right aortic arch (in about 30%), and relatively high position of pulmonary arteries.
ECG commonly shows combined ventricular hypertrophy. Substantial pulmonary overcirculation may produce evidence of left atrial enlargement.
Heart failure is treated vigorously with diuretics, digoxin, and ACE inhibitors, followed by early surgical repair. Prostaglandin infusion is beneficial to maintain ductal patency when there is interruption or coarctation of the aortic arch, in which case right-to-left shunt through the ductus provides systemic blood flow.
Surgical management consists of repair during the neonatal period. The ventricular septal defect is closed so that the left ventricle ejects into the truncal root. Usually, continuity between the right ventricle and the confluence of the pulmonary arteries is achieved using a conduit with or without a valve. Some centers have reported good success using a nonconduit approach, in which the left atrial appendage is used as the posterior wall of the pulmonary outflow and a patch is used as the anterior wall, with or without the insertion of a monocusp valve.
When a conduit is placed during early infancy, its size becomes inadequate as children grow, and the conduit must be revised during childhood. When the patient's own tissue is used for part of this outflow tract, there is the potential for growth of the conduit as the child grows.
Branch pulmonary artery stenosis is a common sequela. Surgical mortality rates have decreased to as low as 10% in recent years.
Endocarditis prophylaxis is recommended preoperatively but is required only for the first 6 mo after repair unless there is a residual defect adjacent to a surgical patch or prosthetic material.
In persistent truncus arteriosus, the primitive truncus does not divide into the pulmonary artery and aorta, resulting in a single large arterial trunk that overlies a large ventricular septal defect (VSD).
Different types are distinguished based on the origin of the pulmonary arteries and associated defects.
Patients present with mild cyanosis, significant pulmonary overcirculation, and heart failure; a grade 2 to 4/6 systolic murmur is audible along the left sternal border and a mid-diastolic mitral flow murmur may be audible at the apex.
Treat heart failure with diuretics, digoxin, and ACE inhibitors; prostaglandin infusion is beneficial to maintain duct patency only in patients with type A4 truncus with interrupted aortic arch or coarctation.
Do surgical repair early; one or more revisions are usually needed as children grow.
Drugs Mentioned In This Article
|Drug Name||Select Trade|